Neuralink devices are investigational and have not been approved by the FDA or other regulatory authorities. These videos feature voluntary clinical trial participants sharing their personal experiences, which may not reflect all participants or future outcomes.
Our engineers recently visited one of our speech restoration study participants for a 72-hour hackathon.
The goal: rapidly prototype as many features as possible to enhance the experience of using Neuralink to communicate with thought.
Here are some of the things we built 🧵
Dr. Nader Pouratian is the principal investigator for the VOICE study (NCT07224256), an early feasibility study of Neuralink’s precise robotically implanted brain-computer interface for communication restoration.
Visit our trials page to learn more about the study and join our Patient Registry:
https://t.co/BL55jk9YMc
Neuralink devices are investigational and have not been approved by the FDA or other regulatory authorities.
Early Neuralink speech restoration data:
We are enabling speech to text and voice at conversational rates in participants with ALS. One participant achieved 75 WPM at 5.8% WER on a 125k-word vocabulary in their first week.
Our clinical trial participants have now used their Neuralink implants for over 50,000 hours, building one of the largest datasets of intracortical neural activity ever.
We used it to pretrain a foundation model for BCI: self-supervised neural encoders that turn noisy, drifting spikes into stable representations.
Some initial results:
• Decoders that keep working for weeks instead of days. For some users, calibration dropped from 10 min/day to 10 min/week
• Teleporting cursors that jump straight to the intended target
• A new cursor-control record of 11.32 bits per second (exceeding the performance of most able-bodied people)
We’re just getting started. Future directions include pooling data across participants, one-shot (or zero-shot) calibration, and an API for the motor cortex.
Read more:
https://t.co/sIQXFUI7pc
Neuralink devices are investigational and have not been approved by the FDA or other regulatory authorities. This video features voluntary clinical trial participants sharing their personal experiences, which may not reflect all participants or future outcomes.
Through the VOICE trial, Terry is using his Neuralink implant to help fine-tune a brain-to-voice interface for himself and others who can’t speak. He trained the algorithm first by miming speech as best he could, then by simply thinking the words and hearing them come out in his own natural voice.
Powered by Grok Voice from @spacexai
Neuralink devices are investigational and have not been approved by the FDA or other regulatory authorities. This video features voluntary clinical trial participants sharing their personal experiences, which may not reflect all participants or future outcomes.
Learn more about Neuralink’s clinical trials: https://t.co/1jn9Jge7tY
Neuralink devices are investigational and have not been approved by the FDA or other regulatory authorities. This video features voluntary clinical trial participants sharing their personal experiences, which may not reflect all participants or future outcomes.